Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Sun Pharma Advanced Research company Limited has developed a dry powder inhaler of compound SPARC1316 for oral inhalation. This clinical study is a Phase I/IIa study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of S0597 administered by oral inhalation to healthy volunteers and asthma patients.
Epistemonikos ID: 34cd2d05d58490c3203bc0ccc5b748e62ee05ce3
First added on: May 11, 2024